A leading DevOps platform for digital health, blueBrix, has unveiled new micro frontends for its Patient Support Program and Remote Patient Monitoring Modules to enable easy integration into digital health applications, while improving standards of care.
The company says that in the evolving landscape of healthcare technology, scalability, modularity, and maintainability are crucial factors in building robust and adaptable applications.
One architectural approach that has gained traction in recent years says blueBrix is micro frontend architecture, which breaks down large monolithic applications into smaller, independent frontend modules for improved scalability, modularity, and user experience.
Operating across four different continents, blueBrix is a DevOps platform for digital health applications which includes a library of configurable (low code no code) and compliant health tech components, modules, APIs, microservices, and micro frontends.
blueBrix has developed and integrated micro frontends to enable application developers, healthcare providers, and pharma to fill feature gaps and enhance existing applications without having too build new technology from scratch.
Read more: Q&A: Is over investment killing digital health?
This includes the development and integration of new major features into its Patient Support Program and Remote Patient Monitoring modules, which now enable pharma and healthcare providers to track and facilitate medication adherence, enhance patient education, and improve assistance for chronic conditions.
This is supported by the development and integration of a dedicated analytics module, which enables users to collate data from the blueBrix platform as well as collating and integrating data from other administrative or clinical applications utilised within the healthcare setting, as well as third-party data visualisation tools, such as Tableau.
“Pressure on healthcare systems across the globe is evolving at a frightening pace – particularly amidst an aging population, who are likely to experience and need support for evolving geriatric ailments, such as Type 2 Diabetes,” said Shameem C Hameed, Founder and CEO of blueBrix.
Hameed continued: “In developing and launching our Patient Support Program and Remote Patient Monitoring features, we can now provide Pharma and Healthcare providers alike with the technology required to roll out new solutions that will enable patients to easily access support remotely, successfully reducing costs while driving patient education and adherence to improve both outcomes and care.
“We are incredibly excited about this latest tech advancement and are already receiving excellent feedback from existing and potential users alike.”
